Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response
Allergy · 2025-08 · 80 (8) · 2410-2413
DOI: 10.1111/all.16670 ↗At a glance
Leserbrief in Allergy, published online on 2025-07-18. Written by Murat Türk and 3 co-authors. Institution: Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Türkiye. Cited 8 times so far (Crossref); 6 references.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
Author keywords
Authors and institutions
- Department of Chest Diseases, Division of Allergy and Clinical Immunology, Erciyes University School of Medicine, Kayseri, Türkiye.
- Department of Dermatology, Kayseri City Education and Research Hospital, University of Health Sciences, Kayseri, Türkiye.
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
- Department of Dermatology, School of Medicine, Bahçeşehir University, Istanbul, Türkiye.
ORCID profiles: Murat Türk, İnsu Yılmaz
Cite
APA
Türk, M., Yılmaz, İ., Ertaş, R., & Kocatürk, E. (2025). Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response. Allergy, 80(8), 2410-2413. https://doi.org/10.1111/all.16670
Vancouver
Türk M, Yılmaz İ, Ertaş R, Kocatürk E. Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response. Allergy. 2025;80(8):2410-2413. doi:10.1111/all.16670
BibTeX
@article{Trk2025,
author = {Türk, Murat and Yılmaz, İnsu and Ertaş, Ragıp and Kocatürk, Emek},
title = {Efficacy of Omalizumab, Dupilumab, and Remibrutinib in Chronic Spontaneous Urticaria: Phase Data and Placebo Response},
journal = {Allergy},
year = {2025},
volume = {80},
number = {8},
pages = {2410--2413},
doi = {10.1111/all.16670}
}
EUVIMED